DMTweet (& vote for our SXSW panel)
a tweet recap by PsyMed Ventures x Business Trip colab (issue #11)
First, a quick favor: Please vote for our three SXSW panels.
This will help us get on stage at SXSW 2023! Today is the last day of voting:
#1: A psychedelic industry overview presentation: Vote here
#2: Panel about how psychedelic medicine can integrate into the healthcare system:
#3: Larger Promise of Psychedelics: Beyond Depression: Vote here
We appreciate your support :)
To vote, create a SXSW account and click the ⬆️ arrow in the top right corner (takes 2 minutes!)
DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.
This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).
Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.
Inclusion = interesting ≠ endorsement.
Let’s get to it….
Until next time,
DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.
Thanks for reading DMTweet! Subscribe to receive new posts and Business Trip podcast episodes.